Masimo Return on Tangible Equity 2010-2025 | MASI
Current and historical return on tangible equity values for Masimo (MASI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Masimo Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.50B | $0.79B | -65.48% |
| 2024-12-31 | $-0.31B | $0.89B | -42.69% |
| 2024-09-30 | $0.08B | $0.69B | 12.27% |
| 2024-06-30 | $0.08B | $0.65B | 13.16% |
| 2024-03-31 | $0.08B | $0.62B | 13.66% |
| 2023-12-31 | $0.08B | $0.61B | 14.41% |
| 2023-09-30 | $0.09B | $0.55B | 16.20% |
| 2023-06-30 | $0.12B | $0.56B | 21.96% |
| 2023-03-31 | $0.12B | $0.56B | 23.80% |
| 2022-12-31 | $0.14B | $0.53B | 20.30% |
| 2022-09-30 | $0.17B | $0.47B | 18.40% |
| 2022-06-30 | $0.19B | $0.43B | 16.81% |
| 2022-03-31 | $0.22B | $1.41B | 16.74% |
| 2021-12-31 | $0.23B | $1.41B | 18.06% |
| 2021-09-30 | $0.23B | $1.29B | 18.97% |
| 2021-06-30 | $0.22B | $1.21B | 18.30% |
| 2021-03-31 | $0.23B | $1.15B | 18.81% |
| 2020-12-31 | $0.24B | $1.23B | 19.72% |
| 2020-09-30 | $0.22B | $1.28B | 18.68% |
| 2020-06-30 | $0.22B | $1.21B | 19.57% |
| 2020-03-31 | $0.21B | $1.15B | 19.54% |
| 2019-12-31 | $0.20B | $1.12B | 19.02% |
| 2019-09-30 | $0.19B | $1.06B | 19.38% |
| 2019-06-30 | $0.20B | $0.99B | 21.27% |
| 2019-03-31 | $0.20B | $0.96B | 22.45% |
| 2018-12-31 | $0.19B | $0.92B | 23.72% |
| 2018-09-30 | $0.14B | $0.86B | 18.35% |
| 2018-06-30 | $0.12B | $0.78B | 16.63% |
| 2018-03-31 | $0.12B | $0.72B | 17.48% |
| 2017-12-31 | $0.13B | $0.68B | 19.30% |
| 2017-09-30 | $0.36B | $0.67B | 59.19% |
| 2017-06-30 | $0.35B | $0.66B | 68.82% |
| 2017-03-31 | $0.34B | $0.59B | 82.66% |
| 2016-12-31 | $0.31B | $0.51B | 99.13% |
| 2016-09-30 | $0.11B | $0.28B | 45.08% |
| 2016-06-30 | $0.10B | $0.25B | 44.25% |
| 2016-03-31 | $0.09B | $0.22B | 39.91% |
| 2015-12-31 | $0.08B | $0.23B | 34.55% |
| 2015-09-30 | $0.08B | $0.22B | 32.26% |
| 2015-06-30 | $0.08B | $0.24B | 30.22% |
| 2015-03-31 | $0.07B | $0.28B | 27.33% |
| 2014-12-31 | $0.07B | $0.26B | 27.44% |
| 2014-09-30 | $0.06B | $0.23B | 22.57% |
| 2014-06-30 | $0.06B | $0.27B | 22.34% |
| 2014-03-31 | $0.07B | $0.30B | 23.99% |
| 2013-12-31 | $0.06B | $0.28B | 22.92% |
| 2013-09-30 | $0.06B | $0.26B | 26.64% |
| 2013-06-30 | $0.06B | $0.24B | 25.78% |
| 2013-03-31 | $0.06B | $0.23B | 25.30% |
| 2012-12-31 | $0.06B | $0.23B | 24.56% |
| 2012-09-30 | $0.06B | $0.26B | 23.20% |
| 2012-06-30 | $0.06B | $0.28B | 23.10% |
| 2012-03-31 | $0.06B | $0.26B | 22.90% |
| 2011-12-31 | $0.06B | $0.27B | 23.99% |
| 2011-09-30 | $0.07B | $0.29B | 25.93% |
| 2011-06-30 | $0.07B | $0.27B | 27.66% |
| 2011-03-31 | $0.06B | $0.24B | 27.92% |
| 2010-12-31 | $0.07B | $0.22B | 33.49% |
| 2010-09-30 | $0.07B | $0.24B | 30.47% |
| 2010-06-30 | $0.07B | $0.22B | 28.39% |
| 2010-03-31 | $0.07B | $0.20B | 27.15% |
| 2009-12-31 | $0.05B | $0.28B | 20.85% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.885B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $176.126B | 21.31 |
| Intuitive Surgical (ISRG) | United States | $170.993B | 70.88 |
| IDEXX Laboratories (IDXX) | United States | $51.626B | 53.45 |
| Edwards Lifesciences (EW) | United States | $46.482B | 30.83 |
| Alcon (ALC) | Switzerland | $42.192B | 28.51 |
| IQVIA Holdings (IQV) | United States | $31.268B | 17.67 |
| DexCom (DXCM) | United States | $29.592B | 44.39 |
| Mettler-Toledo (MTD) | United States | $25.624B | 30.41 |
| STERIS (STE) | Ireland | $22.022B | 24.25 |
| Waters (WAT) | United States | $16.738B | 22.99 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.353B | 0.00 |
| Hologic (HOLX) | United States | $15.084B | 16.34 |
| Sysmex ADR (SSMXY) | Japan | $10.519B | 29.84 |
| Penumbra (PEN) | United States | $9.364B | 68.40 |
| Globus Medical (GMED) | United States | $7.262B | 17.30 |
| Teleflex (TFX) | United States | $5.076B | 8.19 |
| Glaukos (GKOS) | United States | $5.050B | 0.00 |
| TransMedics (TMDX) | United States | $4.287B | 65.15 |
| Integer Holdings (ITGR) | United States | $3.774B | 18.83 |
| PROCEPT BioRobotics (PRCT) | United States | $2.662B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.323B | 13.83 |
| Alphatec Holdings (ATEC) | United States | $2.270B | 0.00 |
| Veracyte (VCYT) | United States | $1.959B | 27.48 |
| Nihon Kohden (NHNKY) | Japan | $1.942B | 22.27 |
| Elekta AB (EKTAY) | Sweden | $1.839B | 16.53 |
| Artivion (AORT) | United States | $1.373B | 128.60 |
| Pulse Biosciences (PLSE) | United States | $1.026B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.009B | 0.00 |
| OPKO Health (OPK) | United States | $1.000B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.992B | 5.68 |
| IRadimed (IRMD) | United States | $0.885B | 42.94 |
| Beta Bionics (BBNX) | United States | $0.687B | 0.00 |
| SiBone (SIBN) | United States | $0.682B | 0.00 |
| AxoGen (AXGN) | United States | $0.625B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.516B | 4.15 |
| OrthoPediatrics (KIDS) | United States | $0.490B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.482B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.457B | 8.11 |
| Pacific Biosciences Of California (PACB) | United States | $0.426B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.352B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.316B | 8.03 |
| RxSight (RXST) | United States | $0.311B | 0.00 |
| Neuronetics (STIM) | United States | $0.300B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.285B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.280B | 19.29 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| 908 Devices (MASS) | United States | $0.227B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.194B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
| Accuray (ARAY) | United States | $0.146B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.093B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.086B | 52.50 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.061B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.047B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.92 |